Management of scleral melt.

Ocul Surf

Department of Ophthalmology, UT Health San Antonio, San Antonio, TX, USA. Electronic address:

Published: January 2023

Scleral melting, while rare, can lead to significant ocular morbidity. Several possible risk factors for scleral melt have been identified, such as infection, autoimmune disease, trauma, and post-surgical state, and these may act in combination with each other. Treatment should be tailored according to the etiology and severity of the scleral melt. Medical management may be indicated, especially in cases of autoimmune-related melt; however, surgical procedures are often necessary due to compromised ocular integrity and limited penetration of medications into the avascular sclera. An understanding of the surgical options available and their operative outcomes is particularly important when choosing the appropriate treatment protocol for each patient.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtos.2022.12.005DOI Listing

Publication Analysis

Top Keywords

scleral melt
12
management scleral
4
melt
4
melt scleral
4
scleral melting
4
melting rare
4
rare lead
4
lead ocular
4
ocular morbidity
4
morbidity risk
4

Similar Publications

Self-retained, cryopreserved amniotic membrane for a scleral defect caused by mitomycin C: A case report.

Am J Ophthalmol Case Rep

December 2024

New York Eye and Ear Infirmary of Mount Sinai, New York, NY, USA.

Purpose: To report a case of scleral melting noted within weeks after symblepharon release and pterygium excision with peri-operative adjuvant topical Mitomycin C (MMC) that was salvaged with in-office cryopreserved membrane.

Observations: A 61-year-old Hispanic gentleman with history of pterygium excision many years prior underwent right nasal pterygium excision and symblepharon release using bare sclera technique followed by topical MMC 0.1 % for a week, 16 years ago.

View Article and Find Full Text PDF

The article is a case report of a very rare case of bilateral herpes simplex virus infection associated with bilateral necrotizing scleritis with scleral melt in an elderly north Indian female of lower middle socioeconomic status. A 65-year-old female presented to our clinic with a wide variety of presentations ranging initially from neurotropic corneal ulcer to necrotizing scleritis with scleral melt for 2 years. The patient records were evaluated and computed.

View Article and Find Full Text PDF

A novel case of neurotrophic keratitis and severe corneal melt requiring surgical management is presented 1 month following trans-scleral cyclodiode for Coats disease and neovascular glaucoma. Risk factors contributing to the complication include previous extracapsular cataract surgery, perioperative use of topical non-steroidal anti-inflammatories and dexamethasone/neomycin, as well as other topical drops containing preservatives such as benzalkonium chloride. Meticulous consideration of preoptimization of the ocular surface and rationalization of perioperative eye drop regimes is discussed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!